123 related articles for article (PubMed ID: 20480234)
1. Kinetics and intrapulmonary disposition of tilmicosin after single and repeated oral bolus administrations to rabbits.
Gallina G; Lucatello L; Drigo I; Cocchi M; Scandurra S; Agnoletti F; Montesissa C
Vet Res Commun; 2010 Jun; 34 Suppl 1():S69-72. PubMed ID: 20480234
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of tilmicosin in equine tissues and plasma.
Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
[TBL] [Abstract][Full Text] [Related]
3. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum.
Clark C; Woodbury M; Dowling P; Ross S; Boison JO
J Vet Pharmacol Ther; 2004 Oct; 27(5):385-7. PubMed ID: 15500580
[No Abstract] [Full Text] [Related]
4. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
Brown SA; Deleeuw NR; Stahl GL; Roof RD
J Vet Pharmacol Ther; 1995 Oct; 18(5):385-7. PubMed ID: 8587160
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens.
Abu-Basha EA; Idkaidek NM; Al-Shunnaq AF
Vet Res Commun; 2007 May; 31(4):477-85. PubMed ID: 17225089
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of tildipirosin in rabbits following single-dose intravenous and intramuscular administration.
Xiong J; Xu Y; He S; Zhang Y; Wang Z; Wang S; Jiang H
J Vet Pharmacol Ther; 2020 Sep; 43(5):448-453. PubMed ID: 32542744
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tilmicosin after oral administration in swine.
Shen J; Li C; Jiang H; Zhang S; Guo P; Ding S; Li X
Am J Vet Res; 2005 Jun; 66(6):1071-4. PubMed ID: 16008233
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with Mycoplasma gallisepticum.
Zhang N; Liu Z; Wei Y; Zhang C; Mao C; Cai Q; Shen X; Ding H
J Vet Pharmacol Ther; 2020 Jul; 43(4):347-354. PubMed ID: 32133660
[TBL] [Abstract][Full Text] [Related]
9. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
11. Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.
Avci T; Elmas M
ScientificWorldJournal; 2014; 2014():869096. PubMed ID: 25177733
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
Lombardi KR; Portillo T; Hassfurther R; Hunter RP
J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
[TBL] [Abstract][Full Text] [Related]
13. Impact of the type of catheter on the absorption of tylvalosin (acetylvaleryltylosin) administered orally to broiler chickens.
Cerdá RO; Petruccelli M; Piscopo M; Origlia J; Landoni M
J Vet Pharmacol Ther; 2010 Apr; 33(2):202-3. PubMed ID: 20444046
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with
Zhang L; Zhao L; Liu Y; Liu J; Li X
J Vet Sci; 2017 Dec; 18(4):431-437. PubMed ID: 28385011
[TBL] [Abstract][Full Text] [Related]
15. Effect of albendazole administration on pharmacokinetic aspects of tylosin in lactating goats.
Atef M; Ramadan A; Darwish AS; Fahim AM
Drug Metab Lett; 2009 Aug; 3(3):137-43. PubMed ID: 19702546
[TBL] [Abstract][Full Text] [Related]
16. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
[TBL] [Abstract][Full Text] [Related]
17. Use of tilmicosin for treatment of pasteurellosis in rabbits.
McKay SG; Morck DW; Merrill JK; Olson ME; Chan SC; Pap KM
Am J Vet Res; 1996 Aug; 57(8):1180-4. PubMed ID: 8836371
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of tylvalosin and 3-O-acetyltylosin attained in the synovial fluid of swine after administration by oral gavage at 50 and 5 mg/kg.
Canning P; Bates J; Hammen K; Coetzee J; Wulf L; Rajewski S; Wang C; Karriker L
J Vet Pharmacol Ther; 2016 Dec; 39(6):621-624. PubMed ID: 27086612
[TBL] [Abstract][Full Text] [Related]
19. Elimination of tilmicosin in lactating ewes.
Atef M; Abo el-Sooud K; Nahed E; Tawfik M
Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of tylosin or florfenicol after a single intramuscular administration at two different doses of tylosin-florfenicol combination in pigs.
Kim MH; Gebru E; Chang ZQ; Choi JY; Hwang MH; Kang EH; Lim JH; Yun HI; Park SC
J Vet Med Sci; 2008 Jan; 70(1):99-102. PubMed ID: 18250580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
